Re:: Letter an quinacrine for treatment of Giardiasis -: J Travel Med 1998;5:228.: Reply

被引：0

作者：

Wolfe, MS ^{[1
]}

机构：

[1] Travelers Med Serv Washington, Washington, DC 20037 USA

来源：

JOURNAL OF TRAVEL MEDICINE | 1999年 / 6卷 / 04期

关键词：

D O I：

10.1111/j.1708-8305.1999.tb00534.x

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：265 / 265

页数：1

共 34 条

[21] Reply to Michael Froehner and Christian Thomas's Letter to the Editor re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019; 75:552-5
Berg, Sebastian
Cole, Alexander
Quoc-Dien Trinh
[J]. EUROPEAN UROLOGY, 2019, 76 (03) : E76 - E77
[22] Reply to Masaki Shiota and Akira Yokomizo's Letter to the Editor re: Robert J. van Soest, Ellen S. de Morree, Charlotte F. Kweldam, et al. Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer. Eur Urol 2015; 67: 981-5
van Soest, Robert J.
de Morree, Ellen S.
Kweldam, Charlotte F.
Wiemer, Erik A. C.
Mathijssen, Ron H. J.
de Wit, Ronald
van Weerden, Wytske M.
[J]. EUROPEAN UROLOGY, 2016, 69 (03) : E43 - E44
[23] Reply to Robert J. van Soest and Ronald de Wit's Letter to the Editor re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033
de Bono, Johann
[J]. EUROPEAN UROLOGY, 2017, 71 (01) : E11 - E11
[24] Reply to Glen Denmer Santok and Koon Ho Rha's Letter to the Editor re: Par Stattin, Fredrik Sandin, Frederik Birkebaek Thomsen, et al. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.023
Stattin, Par
Bratt, Ola
[J]. EUROPEAN UROLOGY, 2017, 71 (04) : E115 - E116
[25] Reply to Amar U. Kishan, William Hall, and Daniel Spratt's Letter to the Editor re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552-5 Comparing Apples to Oranges: A Self-fulfilling Prophecy?
Cole, Alexander P.
Quoc-Dien Trinh
[J]. EUROPEAN UROLOGY, 2019, 75 (05) : E135 - E136
[26] Reply to Mauricio Plata, Cesar Diaz Ritter, and Nicolas Badillo's Letter to the Editor re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.009
Ilie, Gabriela
Rutledge, Robert David Harold
[J]. EUROPEAN UROLOGY, 2023, 84 (01) : E26 - E27
[27] Reply to C. Mary Schooling, Grace Sembajwe and Ilir Agalliu's Letter to the Editor re: Christina G. Jespersen, Mette Norgaard, Michael Borre. Androgen-deprivation Therapy in Treatment of Prostate Cancer and Risk of Myocardial Infarction and Stroke: A Nationwide Danish Population-based Cohort Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.02.002
Jespersen, Christina Gade
Norgaard, Mette
Borre, Michael
[J]. EUROPEAN UROLOGY, 2013, 64 (03) : E61 - E61
[28] Reply to Carmen Gravina, Riccardo Lombardo, and Cosimo De Nunzio's Letter to the Editor re: Yash S. Khandwala, Simon John Christoph Soerensen, Shravan Morisetty, et al. The Association of Tissue Change and Treatment Success During High-intensity Focused Ultrasound Focal Therapy for Prostate Cancer. Eur Urol Focus. In press. https://doi. org/10.1016/j.euf.2022.10.010
Sonn, Geoffrey
Khandwala, Yash
[J]. EUROPEAN UROLOGY FOCUS, 2023, 9 (05): : 822 - 823
[29] Reply to Binghao Zhao, Ruidong Zhang, and Jiaming Wu's Letter to the Editor re: Ana Cavillon, Damien Pouessel, Nadine Houede, et al. Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.011
Cavillon, Ana
Porcher, Raphael
Filleron, Thomas
[J]. EUROPEAN UROLOGY, 2023, 84 (01) : E22 - E23
[30] Reply to Emre Karabay and Ilker Tinay's Letter to the Editor re: Treatment of High-grade Non-muscle-inva- sive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial "NIMBUS". Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.066
Grimm, Marc-Oliver
Caris, Christien
Witjes, Wim P. J.
[J]. EUROPEAN UROLOGY, 2020, 78 (04) : E163 - E164

← 1 2 3 4 →